[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Low‐field MRI: clinical promise and challenges
Modern MRI scanners have trended toward higher field strengths to maximize signal and
resolution while minimizing scan time. However, high‐field devices remain expensive to …
resolution while minimizing scan time. However, high‐field devices remain expensive to …
Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019
Z Ou, J Pan, S Tang, D Duan, D Yu, H Nong… - Frontiers in public …, 2021 - frontiersin.org
Background: Parkinson's disease (PD) is an increasing challenge to public health. Tracking
the temporal trends of PD burden would inform health strategies. Methods: Data of PD …
the temporal trends of PD burden would inform health strategies. Methods: Data of PD …
Anionic nanoplastic contaminants promote Parkinson's disease–associated α-synuclein aggregation
Recent studies have identified increasing levels of nanoplastic pollution in the environment.
Here, we find that anionic nanoplastic contaminants potently precipitate the formation and …
Here, we find that anionic nanoplastic contaminants potently precipitate the formation and …
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Objective To incorporate recent research findings, expert consensus, and patient
perspectives into updated guidance on the use of new acute and preventive treatments for …
perspectives into updated guidance on the use of new acute and preventive treatments for …
[HTML][HTML] Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study …
JD Steinmetz, KM Seeher, N Schiess… - The Lancet …, 2024 - thelancet.com
Background Disorders affecting the nervous system are diverse and include
neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions …
neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions …
Neuroinflammation: friend and foe for ischemic stroke
Stroke, the third leading cause of death and disability worldwide, is undergoing a change in
perspective with the emergence of new ideas on neurodegeneration. The concept that …
perspective with the emergence of new ideas on neurodegeneration. The concept that …
[HTML][HTML] Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
GBD 2016 Stroke Collaborators - The Lancet. Neurology, 2019 - ncbi.nlm.nih.gov
Background Stroke is a leading cause of mortality and disability worldwide and the
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
economic costs of treatment and post-stroke care are substantial. The Global Burden of …
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Parkinson's disease prevalence is rapidly increasing in an aging global population. With this
increase comes exponentially rising social and economic costs, emphasizing the immediate …
increase comes exponentially rising social and economic costs, emphasizing the immediate …
The emerging evidence of the Parkinson pandemic
Neurological disorders are now the leading source of disability globally, and the fastest
growing neurological disorder in the world is Parkinson disease. From 1990 to 2015, the …
growing neurological disorder in the world is Parkinson disease. From 1990 to 2015, the …